{"id":"W2105473363","doi":"10.1200/jco.2005.03.209","title":"Phase II Trial of Neoadjuvant Vincristine, Ifosfamide, and Doxorubicin With Granulocyte Colony-Stimulating Factor Support in Children and Adolescents With Advanced-Stage Nonrhabdomyosarcomatous Soft Tissue Sarcomas: A Pediatric Oncology Group Study","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; Pediatric Oncology Group","funders":"","keywords":"Medicine; Ifosfamide; Vincristine; Doxorubicin; Oncology; Granulocyte colony-stimulating factor; Chemotherapy; Stage (stratigraphy); Internal medicine; Pediatric oncology; Clinical trial; Cyclophosphamide; Cancer; Etoposide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114832,0.0009969714,0.001547731,0.0002519812,0.0002472558,0.0005080354,0.0005988639,0.0007784531,0.001581655],"category_scores_gemma":[0.0008316292,0.0003440569,0.0007761524,0.00033257,0.000826284,0.0004184012,0.0002770812,0.001919006,0.0003355567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001133355,"about_ca_system_score_gemma":0.001735125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009409636,"about_ca_topic_score_gemma":0.002153011,"domain_scores_codex":[0.9995438,0.0002892562,0.00002472086,0.00004935827,0.00003510941,0.00005774761],"domain_scores_gemma":[0.9990039,0.0001925577,0.0002457611,0.00006580908,0.00004259181,0.0004492568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.745469,0.04754102,0.06737437,0.000942197,0.002002889,0.001205362,0.0007292944,0.005192619,0.02773224,0.0003051226,0.00424025,0.09726559],"study_design_scores_gemma":[0.4774416,0.4542294,0.05214826,0.00008203882,0.0006799338,0.001679424,0.0002033122,0.001763159,0.005695859,0.0001582631,0.005896161,0.00002252207],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972041,0.001093232,0.0001707624,0.0001557626,0.00003156492,0.000628161,0.0002940767,0.00001852819,0.0004038487],"genre_scores_gemma":[0.9910547,0.001631526,0.00155922,0.0004379409,0.0001236986,0.002037849,0.002273109,0.00001882571,0.0008631104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001581655,"threshold_uncertainty_score":0.008223057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03969412717600098,"score_gpt":0.4176416777798495,"score_spread":0.3779475506038485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}